Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-24 @ 9:22 PM
NCT ID:
NCT06323304
Eligibility Criteria:
Inclusion Criteria:
* Patients must be diagnosed with allergic rhinitis according to the ARIA 2019 (Allergic Rhinitis and its Impact on Asthma) diagnostic criteria, must be between 18 and 60 years old.
* Must have had typical symptoms of allergic rhinitis for at least 2 years.
* Must provide written informed consent to participate in the study.
* Must be mentally alert and able to communicate effectively.
* Must have vital signs within normal limits (pulse, blood pressure, temperature, respiratory rate, SpO2).
* Must not have any other chronic diseases, including respiratory diseases (asthma, pneumonia, chronic obstructive pulmonary disease, etc.), thyroid disease, autonomic nervous system disorders, hypertension, or diabetes, as determined by medical history.
* Must not have any knowledge of auricular therapy.
Exclusion Criteria:
* Have used decongestants, antihistamines, anticholinergics, or oral corticosteroids within the past 1 week.
* Have undergone auricular acupuncture, auricular acupressure, or other forms of acupuncture for the treatment of other respiratory diseases within the past 6 months.
* Have used stimulants (alcohol, beer, coffee, tobacco) within 24 hours of the study.
* Lesions (scars, tears, scratches, bites) on the left auricle.
* Allergic rhinitis with secondary infection, acute sinusitis or acute exacerbation of chronic sinusitis, or chronic sinusitis.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT06323304
Study Brief:
Protocol Section:
NCT06323304